Inventor · disambiguated record
Andrew Levy
Also filed as: LEVY ANDREW · LEVY ANDREW P
8 granted patents·20 pending applications·113 citations·filing 1994–2019
85Inventor score
Files withLEVY ANDREW13RAPPAPORT FAMILY INST FOR RES4TECHNION RES & DEV FOUNDATION2BERKOWITZ NOAH1BRIGHAM & WOMENS HOSPITAL1
Top patents by PatentIndex Score
28 records- 0187US6251608B1Method of determining a potential of a hyperglycemic patients of developing vascular complicationsTECHNION RES & DEV FOUNDATION·Filed 2000·Granted Jun 26, 2001·30 cites·14 claims
- 0284US6613519B1Method of determining a risk of hyperglycemic patients of developing a cardiovascular diseaseRAPPAPORT FAMILY INST FOR RES·Filed 2001·Granted Sep 2, 2003·18 cites·11 claims
- 0377US7608393B2Methods of predicting a benefit of antioxidant therapy for prevention of cardiovascular disease in hyperglycemic patientsRAPPAPORT FAMILY INST FOR RES·Filed 2003·Granted Oct 27, 2009·5 cites·20 claims
- 0476US5480975AInduction of vascular endothelial growth factor (VEGF) by transition metalsBRIGHAM & WOMENS HOSPITAL·Filed 1994·Granted Jan 2, 1996·48 cites·26 claims
- 0572US6599702B1Method of evaluating a risk of a subject of developing vascular complicationsRAPPAPORT FAMILY INST FOR RES·Filed 2000·Granted Jul 29, 2003·12 cites·15 claims
- 0661US2007218462A1Method of Predicting a Benefit of Antioxidant Therapy for Prevention of Cardiovascular Disease in Hiperglycemic PatientsLEVY ANDREW·Filed 2004·Application pending·0 cites
- 0758US2015118663A1System and Method for Predicting and Communicating Data Relating to a Partner's Mood and SensitivityREVNC INC·Filed 2013·Application pending·0 cites
- 0855US2009137617A1Use of haptoglobin genotyping in diagnosis and treatment of cardiovascular diseaseLEVY ANDREW·Filed 2008·Application pending·0 cites
- 0955US2009246770A1Glycemic control for reduction of cardiovascular disease risk in diabetic patients expressing haptoglobin 2-2LEVY ANDREW·Filed 2008·Application pending·0 cites
- 1052US9518993B2Reagents and methods for detecting a polymorphic proteinRAPPAPORT FAMILY INST FOR RES IN THE MEDICAL SCIENCES·Filed 2014·Granted Dec 13, 2016·0 cites·15 claims
- 1151US12116611B2Method of treating intellectual disability, autism and epilepsy associated with an IQSEC2 mutation and for identifying medicaments for treating the sameTECHNION RES & DEV FOUNDATION·Filed 2019·Granted Oct 15, 2024·0 cites·4 claims
- 1251US8901282B2Reagents and methods for detecting a polymorphic proteinVICTOR JACOB·Filed 2009·Granted Dec 2, 2014·0 cites·12 claims
- 1349US2010041059A1Method of predicting a benefit of antioxidant therapy for prevention of cardiovascular disease in hyperglycemic patientsLEVY ANDREW P·Filed 2009·Application pending·0 cites
- 1448US2011313313A1Device for Detecting Skin Sensitivity and Use of the SameLEVY ANDREW·Filed 2009·Application pending·0 cites
- 1545US2003113830A1Novel antioxidant, nucleic acid constructs encoding same, pharmaceutical compositions containing same and use of same for reducing oxidative-stressRAPPAPORT FAMILY INST FOR RES·Filed 2001·Application pending·0 cites
- 1645US2008213785A1Method of predicting a benefit of antioxidant therapy for prevention or treatment of vasclar disease in hyperglycemic individualsLEVY ANDREW·Filed 2008·Application pending·0 cites
- 1743US2011301186A1Use of haptoglobin genotyping in diagnosis and treatment of cardiovascular diseaseLEVY ANDREW·Filed 2011·Application pending·0 cites
- 1843US2008044399A1Vitamin E supplementation for reducing cardiovascular events in individuals with DM and the Hp 2-2 genotypeLEVY ANDREW·Filed 2007·Application pending·0 cites
- 1943US2011288013A1Glycemic control for reduction of cardiovascular disease risk in diabetic patients expressing haptoglobin 2-2LEVY ANDREW·Filed 2011·Application pending·0 cites
- 2041US2015248534A1System And Method Of Generating A User Interface Display Of Patient Parameter DataDRAEGER MEDICAL SYSTEMS INC·Filed 2013·Application pending·0 cites
- 2140US2007014764A1Reduction in myocardial infarction sizeLEVY ANDREW·Filed 2005·Application pending·0 cites
- 2240US2007101445A1Transgenic mice carrying the HP-2 gene and uses as models for vascular diseasesLEVY ANDREW·Filed 2006·Application pending·0 cites
- 2338US2009074740A1Use of haptoglobin genotyping in diagnosis and treatment of defective reverse cholesterol transport (RCT)BERKOWITZ NOAH·Filed 2008·Application pending·0 cites
- 2438US2004147818A1Portable system for monitoring and processing patient parameters in multiple oprational modesFiled 2003·Application pending·0 cites
- 2538US2009054390A1Use of haptoglobin genotyping in diagnosis and treatment of intraplaque hemorrhage resulting from plaque ruptureLEVY ANDREW·Filed 2008·Application pending·0 cites
- 2638US2009018110A1Haptoglobin genotyping for prognosis and treatment of chronic vasospasm following subarachnoid hemorrhage (SAH)LEVY ANDREW·Filed 2008·Application pending·0 cites
- 2738US2017336420A1Methods and kits for treating cardiovascular diseasesRAPPAPORT FAMILY INSTITUTE FOR RES IN THE MEDICAL SCIENCES·Filed 2015·Application pending·0 cites
- 2830US2006228753A1Methods of detecting a phenotype of a polymorphic proteinLEVY ANDREW·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →